US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Oct. 20 for "Methods of treatments based upon anthracycline responsiveness" (American, Spanish Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,158, issued on Oct. 20, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Methods of treatments based upon anthracycline responsiveness" was invented by Gerald R. Crabtree (Woodside, Calif.), Christina Curtis (Stanford, Calif.), Jose A. Seoane Fernandez (L'Hospitalet de Llobregat, Spain) and Jacob G. Kirkland (Oklahoma City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treatment based on a neoplasm's responsiveness to anthracycline are provided. Chromatin accessibility or expression levels of chromatin regulatory genes are used in some instances to determine whether a neoplasm will respon...